Cargando…
Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find pro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893268/ https://www.ncbi.nlm.nih.gov/pubmed/27259755 http://dx.doi.org/10.1186/s12931-016-0381-0 |
_version_ | 1782435524233920512 |
---|---|
author | Hamsten, Carl Wiklundh, Emil Grönlund, Hans Schwenk, Jochen M. Uhlén, Mathias Eklund, Anders Nilsson, Peter Grunewald, Johan Häggmark-Månberg, Anna |
author_facet | Hamsten, Carl Wiklundh, Emil Grönlund, Hans Schwenk, Jochen M. Uhlén, Mathias Eklund, Anders Nilsson, Peter Grunewald, Johan Häggmark-Månberg, Anna |
author_sort | Hamsten, Carl |
collection | PubMed |
description | BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find proteins in bronchoalveolar lavage (BAL) fluid that can be associated with the disease. METHODS: We developed and performed profiling of 94 selected proteins in BAL fluid and serum samples obtained from newly diagnosed and non-treated patients with sarcoidosis. Using multiplexed immunoassays, a total of 317 BAL and 217 serum samples were analyzed, including asthmatic patients and healthy individuals as controls. RESULTS: Our analyses revealed increased levels of eight proteins in sarcoidosis patients compared to controls. Out of these, fibronectin (FN1) and C-C motif chemokine 2 (CCL2) revealed the strongest associations. In addition, cadherin 5 (CDH5) was found to correlate positively with lymphocyte cell numbers in BAL fluid. CONCLUSIONS: Applying a high throughput proteomics screening technique, we found proteins of potential clinical relevance in the context of sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-016-0381-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4893268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48932682016-06-05 Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients Hamsten, Carl Wiklundh, Emil Grönlund, Hans Schwenk, Jochen M. Uhlén, Mathias Eklund, Anders Nilsson, Peter Grunewald, Johan Häggmark-Månberg, Anna Respir Res Research BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find proteins in bronchoalveolar lavage (BAL) fluid that can be associated with the disease. METHODS: We developed and performed profiling of 94 selected proteins in BAL fluid and serum samples obtained from newly diagnosed and non-treated patients with sarcoidosis. Using multiplexed immunoassays, a total of 317 BAL and 217 serum samples were analyzed, including asthmatic patients and healthy individuals as controls. RESULTS: Our analyses revealed increased levels of eight proteins in sarcoidosis patients compared to controls. Out of these, fibronectin (FN1) and C-C motif chemokine 2 (CCL2) revealed the strongest associations. In addition, cadherin 5 (CDH5) was found to correlate positively with lymphocyte cell numbers in BAL fluid. CONCLUSIONS: Applying a high throughput proteomics screening technique, we found proteins of potential clinical relevance in the context of sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-016-0381-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-04 2016 /pmc/articles/PMC4893268/ /pubmed/27259755 http://dx.doi.org/10.1186/s12931-016-0381-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hamsten, Carl Wiklundh, Emil Grönlund, Hans Schwenk, Jochen M. Uhlén, Mathias Eklund, Anders Nilsson, Peter Grunewald, Johan Häggmark-Månberg, Anna Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title_full | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title_fullStr | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title_full_unstemmed | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title_short | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
title_sort | elevated levels of fn1 and ccl2 in bronchoalveolar lavage fluid from sarcoidosis patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893268/ https://www.ncbi.nlm.nih.gov/pubmed/27259755 http://dx.doi.org/10.1186/s12931-016-0381-0 |
work_keys_str_mv | AT hamstencarl elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT wiklundhemil elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT gronlundhans elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT schwenkjochenm elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT uhlenmathias elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT eklundanders elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT nilssonpeter elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT grunewaldjohan elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients AT haggmarkmanberganna elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients |